CID 10066285

Sr-14136

Structural Information

Molecular Formula
C22H25N3O
SMILES
C1C[C@@H]2C[C@@H](CCN2[C@@H](C1)C3=CC=CC=C3)N4C5=CC=CC=C5NC4=O
InChI
InChI=1S/C22H25N3O/c26-22-23-19-10-4-5-11-21(19)25(22)18-13-14-24-17(15-18)9-6-12-20(24)16-7-2-1-3-8-16/h1-5,7-8,10-11,17-18,20H,6,9,12-15H2,(H,23,26)/t17-,18-,20+/m1/s1
InChIKey
KMUYAJQKQQUKSQ-GGPKGHCWSA-N
Compound name
3-[(2R,6S,9aR)-6-phenyl-2,3,4,6,7,8,9,9a-octahydro-1H-quinolizin-2-yl]-1H-benzimidazol-2-one
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

347.19977 Da
Monoisotopic Mass

3.8
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 348.207046 184.5
[M+Na]+ 370.188988 190.6
[M-H]- 346.192494 189.6
[M+NH4]+ 365.233593 195.8
[M+K]+ 386.162928 182.1
[M+H-H2O]+ 330.197030 172.7
[M+HCOO]- 392.197971 196.4
[M+CH3COO]- 406.213621 192.4
[M+Na-2H]- 368.174436 185.5
[M]+ 347.19922142 177.8
[M]- 347.20031858 177.8
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.